Airtel, Apollo, AWS carry out AI-guided colonoscopy trial
Bharti Airtel, India’s premier communications solutions provider and Apollo Hospitals, Asia’s foremost trusted integrated healthcare group announced that they have carried out India’s first 5G driven, artificial intelligence (AI) guided colonoscopy trial.
Bharti Airtel falls more than 4% after JP Morgan downgrade
Hyderabad: Bharti Airtel, India's premier communications solutions provider and Apollo Hospitals, Asia's foremost trusted integrated healthcare group announced that they have carried out India's first 5G driven, artificial intelligence (AI) guided colonoscopy trial. The trial was conducted using AI on Airtel's 5G technology with ultra-low latency and high processing capabilities as a result of which the colon cancer got detected much faster and with greater accuracy. HealthNet Global, AWS and Avesha are the other three companies that collaborated in this trial.
Ajay Chitkara, CEO and Director, Airtel Business said, "Ultra-fast, low latency 5G networks will transform the Healthcare sector in the country. At Airtel, we are geared up to lead this transformation and have demonstrated this by conducting India's first colonoscopy trials."
He further said, "Healthcare is one of the most promising use cases for 5G, and we are delighted to collaborate Apollo Hospitals, AWS, HealthNet Global and Avesha. This is just the beginning, and I am certain we will bring many more innovative use cases that will help redefine healthcare in the country."
"By augmenting doctor's ability to detect, AI has been proved to improve physician's accuracy. Early detection and removal of polyps can easily avoid them becoming cancerous. Apollo has always been a fore runner in adoption of technology," said Dr. Sangita Reddy, Joint MD, Apollo Hospitals Group.
